Tyler B. Johnson

790 total citations
28 papers, 485 citations indexed

About

Tyler B. Johnson is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Tyler B. Johnson has authored 28 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Physiology and 10 papers in Cell Biology. Recurrent topics in Tyler B. Johnson's work include Lysosomal Storage Disorders Research (14 papers), Cellular transport and secretion (9 papers) and Retinal Development and Disorders (4 papers). Tyler B. Johnson is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Cellular transport and secretion (9 papers) and Retinal Development and Disorders (4 papers). Tyler B. Johnson collaborates with scholars based in United States, Serbia and Germany. Tyler B. Johnson's co-authors include Jill M. Weimer, Katherine A. White, Jacob T. Cain, David A. Pearce, Paul Blum, Denia Ramirez‐Montealegre, Yukari Maezato, Karl Dana, Brian D. Shaw and Zachary Schultzhaus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Tyler B. Johnson

28 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tyler B. Johnson United States 12 247 194 127 72 48 28 485
Malene Bredahl Hansen Denmark 12 531 2.1× 220 1.1× 217 1.7× 24 0.3× 38 0.8× 24 1.3k
Sergio Domenico Gadau Italy 13 253 1.0× 58 0.3× 47 0.4× 53 0.7× 8 0.2× 44 661
Silvia Mioletti Italy 11 249 1.0× 38 0.2× 33 0.3× 28 0.4× 13 0.3× 20 493
Abdul Hameed Pakistan 12 346 1.4× 28 0.1× 91 0.7× 146 2.0× 12 0.3× 21 620
Ruth G. Jones United States 15 222 0.9× 78 0.4× 44 0.3× 66 0.9× 11 0.2× 37 560
Gerardo Ramos‐Mandujano Mexico 16 350 1.4× 114 0.6× 154 1.2× 29 0.4× 8 0.2× 34 702
Vrinda Sreekumar India 11 221 0.9× 39 0.2× 47 0.4× 121 1.7× 9 0.2× 19 492
K. Adam Bohnert United States 11 302 1.2× 43 0.2× 194 1.5× 10 0.1× 11 0.2× 26 488
Gianfranco Matrone United Kingdom 11 221 0.9× 76 0.4× 69 0.5× 23 0.3× 36 0.8× 14 496
Anqi Qin United States 18 512 2.1× 93 0.5× 56 0.4× 67 0.9× 4 0.1× 30 783

Countries citing papers authored by Tyler B. Johnson

Since Specialization
Citations

This map shows the geographic impact of Tyler B. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler B. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler B. Johnson more than expected).

Fields of papers citing papers by Tyler B. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler B. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler B. Johnson. The network helps show where Tyler B. Johnson may publish in the future.

Co-authorship network of co-authors of Tyler B. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler B. Johnson. A scholar is included among the top collaborators of Tyler B. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler B. Johnson. Tyler B. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swier, Vicki J., Katherine A. White, Tyler B. Johnson, et al.. (2024). NF1+/ex42del miniswine model the cellular disruptions and behavioral presentations of NF1‐associated cognitive and motor impairment. Clinical and Translational Science. 17(6). e13858–e13858. 3 indexed citations
2.
Johnson, Tyler B., Shibi Likhite, Katherine A. White, et al.. (2023). Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease. Frontiers in Genetics. 14. 9 indexed citations
3.
Swier, Vicki J., Katherine A. White, Tyler B. Johnson, et al.. (2023). A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes. Disease Models & Mechanisms. 16(8). 5 indexed citations
4.
Holmes, Andrew D., Katherine A. White, Tyler B. Johnson, et al.. (2022). Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8mnd mice. Orphanet Journal of Rare Diseases. 17(1). 411–411. 4 indexed citations
5.
6.
Swier, Vicki J., Katherine A. White, Tyler B. Johnson, et al.. (2022). A Novel Porcine Model of CLN2 Batten Disease that Recapitulates Patient Phenotypes. Neurotherapeutics. 19(6). 1905–1919. 7 indexed citations
7.
White, Katherine A., Hemanth R. Nelvagal, Bin Lü, et al.. (2021). Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice. Molecular Therapy — Methods & Clinical Development. 20. 497–507. 11 indexed citations
8.
Jodelka, Francine M., Anthony J. Hinrich, Tyler B. Johnson, et al.. (2020). Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease. Nature Medicine. 26(9). 1444–1451. 34 indexed citations
9.
Johnson, Tyler B., Katherine A. White, Jacob T. Cain, et al.. (2020). AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease. Molecular Therapy. 29(1). 162–175. 30 indexed citations
10.
Johnson, Tyler B., Kimmo Lehtimäki, Jacob T. Cain, et al.. (2020). A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease. Progress in Neurobiology. 189. 101789–101789. 5 indexed citations
11.
Johnson, Tyler B., et al.. (2020). A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease. Scientific Reports. 10(1). 10591–10591. 14 indexed citations
12.
Johnson, Tyler B., Jacob T. Cain, Katherine A. White, et al.. (2019). Therapeutic landscape for Batten disease: current treatments and future prospects. Nature Reviews Neurology. 15(3). 161–178. 119 indexed citations
13.
Johnson, Tyler B., et al.. (2019). Methylation deficiency of chromatin proteins is a non-mutational and epigenetic-like trait in evolved lines of the archaeon Sulfolobus solfataricus. Journal of Biological Chemistry. 294(19). 7821–7832. 5 indexed citations
14.
Johnson, Tyler B., et al.. (2019). Changes in motor behavior, neuropathology, and gut microbiota of a Batten disease mouse model following administration of acidified drinking water. Scientific Reports. 9(1). 14962–14962. 19 indexed citations
15.
Cain, Jacob T., et al.. (2019). Tracking sex-dependent differences in a mouse model of CLN6-Batten disease. Orphanet Journal of Rare Diseases. 14(1). 19–19. 13 indexed citations
16.
17.
Cain, Jacob T., Shibi Likhite, Katherine A. White, et al.. (2019). Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease. Molecular Therapy. 27(10). 1836–1847. 27 indexed citations
18.
Johnson, Tyler B., et al.. (2018). Secretion and fusion of biogeochemically active archaeal membrane vesicles. Geobiology. 16(6). 659–673. 6 indexed citations
19.
Johnson, Tyler B., Jacob T. Cain, Stephen R. Braddock, et al.. (2018). Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1. Scientific Reports. 8(1). 16161–16161. 6 indexed citations
20.
Cho, Kevin, et al.. (2017). Methylenetetrahydrofolate Reductase A1298C Polymorphism and Major Depressive Disorder. Cureus. 9(10). e1734–e1734. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malene Bredahl Hansen Breakdown of academic impact, for papers by Sergio Domenico Gadau Breakdown of academic impact, for papers by Silvia Mioletti Breakdown of academic impact, for papers by Abdul Hameed Breakdown of academic impact, for papers by Ruth G. Jones Breakdown of academic impact, for papers by Gerardo Ramos‐Mandujano Breakdown of academic impact, for papers by Vrinda Sreekumar Breakdown of academic impact, for papers by K. Adam Bohnert Breakdown of academic impact, for papers by Gianfranco Matrone Breakdown of academic impact, for papers by Anqi Qin
Rankless by CCL
2026